Regenerative & Repair
Multi-Peptide Repair Blend Studies
Quantity
Ships from the United States with tracking · free shipping over $200
Certificates of analysis
Each certificate covers one production run, and reports on that batch alone. Open any of them to read the laboratory report exactly as the third-party lab issued it.
Authenticity
Scan the code on the label to pull up every published certificate for that compound — the same reports the third-party laboratory issued, batch by batch. Traceable from the laboratory that tested it to your bench.
Verify a batch →Independently tested
Purity is quantified by reverse-phase HPLC and identity confirmed by mass spectrometry, by an outside laboratory rather than in-house.
A certificate for your lot
The report that ships with your order describes the batch you received — not the product line, and not a representative sample.
COA-backed replacement
If material does not match the certificate issued for its lot, we replace it or refund it. Send us the lot number and we will trace it.
Tracked dispatch
Tracking is issued when the label is created, so the shipment is traceable from the moment it leaves us.
About this compound
Mixture (GHK-Cu + TB-500 + BPC-157 + KPV)
KLOW combines four peptides from tissue-repair research, freeze-dried together at 80 mg total. The published literature covers the individual constituents — spanning collagen signaling, actin dynamics and inflammatory pathways — rather than the blend itself.
Full specification
How it works
The pathways KLOW Blend acts on, and what each one does. Signalling described from preclinical models.
Tissue Repair & Angiogenesis
Two of the four constituents contribute here by different routes — one through growth-factor and angiogenic signalling, the other through actin dynamics and cell migration. The published research addresses each separately; none of it addresses the blend.
Matrix & Collagen Support
The copper-peptide component supplies the matrix arm, studied for collagen and elastin synthesis and for fibroblast migration. In isolation it is the most heavily documented of the four constituents.
Inflammation Modulation
The alpha-MSH-derived tripeptide is reported to inhibit NF-κB and MAP-kinase signalling at nanomolar concentrations, contributing anti-inflammatory activity without the pigmentation effects the parent hormone carries.
Uses & applications
The main areas under study, and the study-reported figures behind them.
The orthopaedic literature addresses the individual constituents, principally the two repair peptides, rather than the blend.
Sikiric et al. 1998
Migration and vessel-formation endpoints come from the actin-binding and angiogenic components respectively.
Ortho Sports Med. Review
The copper-peptide component carries this area, which has the deepest independent literature of the four.
Therapeutic Peptides Review
Review-level sources rather than primary trials. Worth reading as orientation, not as evidence for the combination.
Injectable Peptide Therapy Primer
What the published work measures
The endpoints reported across the literature for this compound. The figures belong to the individual papers, not to us.
What is in the vial
This product is a mixture, so it has no single structure. These are the compounds it is blended from, each shown on its own.
GHK-Cu
Drag to rotate
48 atoms
48 atoms, 48 bonds, C14H24N6O4. Deposited conformer from PubChem CID 73587, not a drawing.
TB-500
Drag to rotate
62 atoms
62 atoms, 61 bonds, C38H68N10O14. Connectivity and stereochemistry from PubChem CID 62707662. The arrangement is one computed low-energy conformer, not a measured structure — a flexible peptide adopts many conformations in solution. Hydrogens omitted for legibility.
BPC-157
Drag to rotate
100 atoms
100 atoms, 103 bonds, C62H98N16O22. Connectivity and stereochemistry from PubChem CID 9941957. The arrangement is one computed low-energy conformer, not a measured structure — a flexible peptide adopts many conformations in solution. Hydrogens omitted for legibility.
KPV
Drag to rotate
54 atoms
54 atoms, 54 bonds, C16H30N4O4. Deposited conformer from PubChem CID 125672, not a drawing.
Mixture (GHK-Cu + TB-500 + BPC-157 + KPV)
Third-party verified
Every batch of KLOW Blend is sent to an accredited independent laboratory before it ships. Here is what we screen for.
Quantifies purity and reports it on the lot certificate
Verifies the exact molecular identity
Lead, arsenic, cadmium & mercury
Bacterial endotoxin levels
No microbial contamination
Actual peptide mass per vial verified
FAQ
KLOW combines four peptides from tissue-repair research, freeze-dried together at 80 mg total. The published literature covers the individual constituents — spanning collagen signaling, actin dynamics and inflammatory pathways — rather than the blend itself.
Published research on KLOW Blend concentrates on Tendon, Muscle & Connective Tissue, Cell Migration & Angiogenesis, Skin, Collagen & Wound Models and Recovery & Repair Pharmacology. Each of those areas is summarised further up this page with the citation it comes from, and the full reference list — 4 indexed publications — sits at the bottom. Study designs and concentrations vary considerably between publications, so the primary sources are worth reading directly.
The literature describes KLOW Blend acting across Tissue Repair & Angiogenesis, Matrix & Collagen Support and Inflammation Modulation, reported respectively as BPC-157 + TB-500, GHK-Cu and KPV. Those pathways are drawn from preclinical models rather than clinical work, and they describe what has been observed rather than a settled mechanism — the individual pathway cards above cite what each one is based on.
KLOW Blend has a molecular formula of Mixture (GHK-Cu + TB-500 + BPC-157 + KPV). It ships as lyophilized powder. Those are nominal reference values for the parent compound. The identity of the specific material you receive is confirmed by mass spectrometry and reported on that lot's certificate.
Store the sealed vial at -20°C, protected from light and moisture, and let it reach room temperature before opening so condensation does not form on cold powder. Keep reconstituted solution refrigerated and avoid repeated freeze-thaw cycles — solutions are far less stable than lyophilized powder.
No. KLOW Blend is supplied strictly for in-vitro laboratory research and development. It is not a drug, food, supplement or cosmetic, it has not been evaluated by the FDA, and it is not intended for human or animal consumption, ingestion, injection or any in-vivo use. Ordering confirms you are a qualified researcher or institution purchasing on that basis.
Cited sources
Independent published research indexed from PubMed and peer-reviewed journals — not Routine Peptides claims.
For research use only
Not for human or veterinary use. For in-vitro laboratory research only. These statements have not been evaluated by the FDA; this product is not intended to diagnose, treat, cure, or prevent any disease. Sold exclusively to qualified researchers and institutions.
Before you order
Every production run is analyzed by an independent laboratory, and the certificate for your lot travels with the order — not a catalog-wide document, and not a summary written by us.
